A detailed history of Avantax Advisory Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 89,292 shares of NVO stock, worth $7.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
89,292
Previous 97,686 8.59%
Holding current value
$7.8 Million
Previous $13.9 Million 23.75%
% of portfolio
0.07%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $999,473 - $1.22 Million
-8,394 Reduced 8.59%
89,292 $10.6 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $6.88 Million - $8.23 Million
56,040 Added 134.56%
97,686 $13.9 Million
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $660,447 - $879,130
6,468 Added 18.39%
41,646 $5.35 Million
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $380,175 - $456,703
4,331 Added 14.04%
35,178 $3.64 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $1.7 Million - $3.72 Million
18,653 Added 152.97%
30,847 $2.81 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $315,547 - $349,270
2,023 Added 19.89%
12,194 $1.97 Million
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $11,248 - $13,526
85 Added 0.84%
10,171 $1.62 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $59,171 - $78,085
577 Added 6.07%
10,086 $1.36 Million
Q3 2022

Nov 01, 2022

SELL
$95.28 - $116.93 $30,966 - $38,002
-325 Reduced 3.3%
9,509 $947,000
Q2 2022

Aug 02, 2022

SELL
$103.24 - $121.81 $106,233 - $125,342
-1,029 Reduced 9.47%
9,834 $1.1 Million
Q1 2022

Apr 27, 2022

BUY
$93.1 - $112.54 $158,549 - $191,655
1,703 Added 18.59%
10,863 $1.2 Million
Q4 2021

Jan 24, 2022

SELL
$95.88 - $117.08 $17,162 - $20,957
-179 Reduced 1.92%
9,160 $1.03 Million
Q3 2021

Oct 21, 2021

SELL
$84.42 - $106.62 $11,734 - $14,820
-139 Reduced 1.47%
9,339 $895,000
Q2 2021

Jul 29, 2021

BUY
$67.66 - $84.76 $14,411 - $18,053
213 Added 2.3%
9,478 $796,000
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $292,851 - $331,105
4,367 Added 89.16%
9,265 $624,000
Q4 2020

Jan 22, 2021

SELL
$63.89 - $73.8 $333,378 - $385,088
-5,218 Reduced 51.58%
4,898 $342,000
Q3 2020

Oct 14, 2020

BUY
$63.69 - $70.22 $408,889 - $450,812
6,420 Added 173.7%
10,116 $702,000
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $2,692 - $3,125
46 Added 1.26%
3,696 $242,000
Q1 2020

Apr 30, 2020

SELL
$49.46 - $64.78 $4,847 - $6,348
-98 Reduced 2.61%
3,650 $221,000
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $186,875 - $218,358
3,748 New
3,748 $217,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.